AstraZeneca PLC (AZN) is expected to report earnings on Friday, October 30, 2026, after the close. Consensus EPS estimate is $2.64.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-27 | FY2026 Q2 | $2.50 | $2.63 | +5.2% | $15.38B |
| 2026-04-29 | FY2026 Q1 | $2.57 | $1.99 | -22.6% | $15.29B |
| 2026-02-24 | FY2025 Q4 | $2.09 | $2.12 | +1.4% | $15.50B |
| 2025-11-06 | FY2025 Q3 | $2.28 | $1.63 | -28.5% | $15.19B |
| 2025-07-29 | FY2025 Q2 | $2.18 | $1.58 | -27.5% | $14.46B |
| 2025-03-30 | FY2025 Q1 | $2.20 | $2.48 | +12.7% | $13.59B |
| 2024-12-31 | FY2024 Q4 | $2.07 | $2.10 | +1.4% | $14.89B |
| 2024-09-30 | FY2024 Q3 | $2.02 | $2.08 | +3.0% | $13.56B |
AZN has beaten consensus EPS in 5 of its last 8 reported quarters.
See AZN on the live calendar →